What doesn't J&J produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
April 7 - News
It was truly an amazing first quarter for the Dow Jones Industrial Average (INDEXDJX:.DJI). The U.S.
Keep Reading →
April 7 - News
If you'd only read the headlines, you'd think it was a rough week on Wall Street.
Keep Reading →
April 7 - News
Benjamin Graham’s oldest student, who is still alive, is 106-year-old Irving Kahn.
Keep Reading →
April 7 - Hedge Funds
Making money in business typically happens in one of two ways. You either sell a relatively low-cost product to a large number of customers.
Keep Reading →
April 4 - News
There might be economic gloom on the horizon enough to send the Dow Jones Industrial Average (Dow Jones Indices:.DJI) tumbling 111 points, but Merck & Co., Inc.
Keep Reading →
April 4 - News
For once, the stock market wasn't able to recover from its losses, as the Dow Jones Industrial Average (INDEXDJX:.DJI) backed off from their record highs yesterday in giving up...
Keep Reading →
April 4 - News
This has been a great year so far for Wall Street: The Dow Jones Industrial Average is already up more than 11% in a year characterized by record-setting highs and massive corporate...
Keep Reading →
April 3 - News
It took a few hours to sink in, but investors sold off stocks after some weak economic data was reported this morning.
Keep Reading →
April 3 - News
Here's my favorite headline of the day: "Retail Investors Are Back! But Don't Hit 'Sell' Yet," courtesy of our friends over at CNBC. The point of the article is simple.
Keep Reading →
April 3 - News
The Dow Jones Industrial Average 2 Minute is down following a troubling private sector jobs report, having lost 67 points, or 0.46%, as of 1:15 p.m. EDT.
Keep Reading →
April 3 - News
The Dow Jones Industrial Average 2 Minute rose higher by 89 points, or 0.61%, today, after positive factory orders data and a higher-than-expected Medicare reimbursement rate ...
Keep Reading →
April 3 - News
The index has hit a new intraday record high in its latest surge, and as of 2:15 p.m. EDT the Dow has advanced 95 points, or 0.6%.
Keep Reading →
April 2 - News
The drug, Invokana, the very first of its kind, was given the okay after nine clinical trials involving more than 10,000 patients with Type 2 diabetes.
Keep Reading →
April 2 - News
Let’s try to make our investing life easy! Let’s stop buying and selling every single week; instead, let's buy those stocks that will (hopefully) be around decades from now...
Keep Reading →
April 2 - News
AbbVie Inc (NYSE:ABBV) investors should be aware of an increase in hedge fund sentiment of late, and we'll compare the company to peers like GlaxoSmithKline plc (ADR) (NYSE:GSK...
Keep Reading →
April 2 - News
LONDON -- If you're interested in building a profitable, diversified portfolio, then you will often need to compare similar companies when choosing which share to buy next.
Keep Reading →
March 31 - News
Recently, with the loss of patents causing generic competition, the main attraction to pharmaceutical companies has been their dividend.
Keep Reading →
March 29 - News
The broad-based S&P 500 (S&P Indices:.INX) may be having one heck of a time trying to eclipse its previous all-time high, but that hasn't stopped a breathtaking 54% of companies...
Keep Reading →
March 28 - News
It's been quite a while since we had a big wedding in the pharma world.
Keep Reading →
March 28 - News
After a wildly successful IPO that raised over $2 billion, and valued the newly-created company at more than $12 billion, pharmaceutical giant Pfizer Inc.
Keep Reading →
March 28 - News
The Dow Jones Industrial Average has been anything but consistent this week, dropping back into the red today after yesterday's gains. As of 2:15 p.m.
Keep Reading →
March 27 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 27 - News
For the last several years, Merck & Co., Inc.
Keep Reading →
March 26 - News
Pfizer Inc. (NYSE:PFE) is the largest healthcare company in the world in terms of market capitalization.
Keep Reading →
March 26 - News
Normally, our weekly look at what's going on within the health-care sectors involves a mixture of health-care conferences, FDA panel meetings and decisions, and a plethora of ...
Keep Reading →
March 24 - News
In this series, we'll highlight four companies in an industry, and compare their "cash king margins" over time, trying to determine which has the greatest likelihood of putting...
Keep Reading →
March 22 - News
It’s almost here! Johnson & Johnson (NYSE:JNJ) is eagerly awaiting a decision on its type 2 diabetes drug Invokana (canagliflozin) by the end of the month.
Keep Reading →
March 22 - News
The demand for drugs worldwide is expected to increase due to emerging markets abroad and more specifically, due to an influx of demand from the aging "Baby Boomers" domestically...
Keep Reading →
March 20 - News
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
Keep Reading →
March 19 - News
"Dogs of the Dow" is one of the simplest dividend strategies to beat the market.
Keep Reading →
March 18 - News
One thing that many investors become fixated on is always wanting the next 'hot tip' or the 'inside word.' Forever seeking an edge on everyone else, investors seek the holy grail...
Keep Reading →
March 18 - News
Lately, the stock market has seemed to look for any excuse to rise, and today was no exception.
Keep Reading →
March 15 - News
Once again, the Dow Jones Industrial Average is pushing higher today. As of 12:55 p.m. EDT, the index has added 64 points, or 0.44%.
Keep Reading →
March 14 - News
An Apple a day might not keep the doctor away, but the company's AppStore carries several solutions for tracking health care on the go -- and pharmaceutical companies continue...
Keep Reading →
March 14 - News
After seeing MannKind Corporation (NASDAQ:MNKD) rocket upwards over the last week, Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to ...
Keep Reading →
March 13 - News
Aside from a former partnership with Royal Dutch Shell plc (ADR) (NYSE:RDS-A), industrial biotechnology company Codexis, Inc.
Keep Reading →
March 13 - News
It's a quiet day on the economic front, giving investors little reason to move markets sharply higher or lower. As of 3:20 p.m.
Keep Reading →
March 13 - News
The Dow Jones Industrial Average is trading within a tight range today, and as of noon it sits less than four points above breakeven.
Keep Reading →
March 13 - News
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won't just fall into your lap.
Keep Reading →
March 13 - News
Well, the streak almost came to an end, but the Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI) eked out another win today, its eighth in a row.
Keep Reading →
March 13 - News
The Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI) is down slightly after finishing higher for the past six trading sessions. As of 1:15 p.m.
Keep Reading →
March 13 - News
What doesn't Johnson & Johnson (NYSE:JNJ) produce? From pharmaceuticals to consumer care goods to medical devices, this major medical player has it all.
Keep Reading →
March 13 - News
As the Dow Jones Industrials continues to forge ahead to new highs, many investors have become anxious about just how long the bull-market run can last.
Keep Reading →
March 12 - News
The Motley Fool recently whittled down 1,700 public companies to name its list of The 25 Best Companies in America. Merck & Co., Inc.
Keep Reading →
March 12 - News
They say that most bull markets end with a final bout of exuberance, and that certainly looks like what might be happening with the stock market these days.
Keep Reading →
March 11 - News
Flip to the 2012 financial results for AbbVie Inc (NYSE:ABBV) and you'll see that its best-selling drug, Humira, brought in $9.27 billion in 2012, or 51% of the company's total...
Keep Reading →
March 11 - News
Cancer just might be one of the scariest words in the English language. What goes through your mind when you hear that someone close to you has cancer? Sadness, probably.
Keep Reading →
March 11 - News
That's hardly the most shocking statistic of the obesity epidemic, America's most serious ongoing crisis.
Keep Reading →
March 10 - News
For three days running, the Dow Jones Industrials have set new all-time record highs.
Keep Reading →
March 8 - News